|
| Exchange Disseminated Time 01/12/2015 08:12:58 | | Sun Pharmaceutical Industries Ltd has informed BSE that pursuant to Regulation 30(5) of the Securities And Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, Mr. Dilip Shanghvi, Managing Director, Mr. Sudhir V. Valia, Whole Time Director, Mr. Sailesh Desai Whole Time Director, Mr. Uday Baldota, CFO and Mr. Sunil Ajmera, Company Secretary have been authorised severally to determine materiality of an event or information and for making disclosures to Stock Exchange(s). |
|
|